Why is Indrapr.Medical falling/rising?

As of 21-Jul, Indraprastha Medical Corporation Ltd is experiencing a decline in its stock price, currently at 476.10, which reflects a decrease of 10.85 points or 2.23%. Today's price summary indicates that the stock underperformed its sector by 1.56%, with an intraday low of Rs 474.7, marking a 2.52% drop. Despite its strong long-term performance, with a 101.91% return over the past year and consistent positive results for the last 12 quarters, the stock has faced challenges recently, including a significant drop in investor participation, as evidenced by a 47.6% decrease in delivery volume compared to the 5-day average. While the company boasts high management efficiency and a low debt-to-equity ratio, these strengths have not been sufficient to counteract the recent price decline.
In the broader market context, the stock's short-term performance has been notably weaker than the benchmark, with a 1-week return of -4.21% compared to a negligible -0.06% change in the Sensex. This underperformance highlights the stock's struggle to maintain momentum despite its impressive long-term growth metrics, such as a 30.21% annual growth rate in operating profit and a favorable PEG ratio of 0.9. The current market conditions, characterized by falling investor participation and a premium valuation relative to peers, suggest that the stock may be facing headwinds that are impacting its price negatively in the short term.